Cannabidiol for functional seizures (psychogenic nonepileptic seizures/attacks) and other stress‐associated disorders
Epilepsia Open · 2023
DOI: 10.1002/epi4.12805 ↗Kurz gefasst
Leserbrief in der Zeitschrift Epilepsia Open, 2023. Verfasst von Ali A Asadi-Pooya. Beteiligte Einrichtung: Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Cannabidiol, Conversion Disorder. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Ali A Asadi-Pooya
Zitieren
APA
Asadi-Pooya, A. A. (2023). Cannabidiol for functional seizures (psychogenic nonepileptic seizures/attacks) and other stress‐associated disorders. Epilepsia Open. https://doi.org/10.1002/epi4.12805
Vancouver
Asadi-Pooya AA. Cannabidiol for functional seizures (psychogenic nonepileptic seizures/attacks) and other stress‐associated disorders. Epilepsia Open. 2023. doi:10.1002/epi4.12805
BibTeX
@article{AsadiPooya2023,
author = {Asadi-Pooya, Ali A},
title = {Cannabidiol for functional seizures (psychogenic nonepileptic seizures/attacks) and other stress‐associated disorders},
journal = {Epilepsia Open},
year = {2023},
doi = {10.1002/epi4.12805}
}
EUVIMED